TCTR20210929006已完成不适用
Renal Cell Carcinoma Database For Clinical Characteristics and Tissue Mutations in Metastatic RCC Patients
/A0 个研究点目标入组 281 人开始时间: 2021年9月29日最近更新:
适应症
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 发起方
- 入组人数
- 281
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 18 Years 至 99 Years（—）
- 性别
- All
入选标准
- •1. Kidney cancer who had evidenced with pathological reports
- •2. Available data in Ramathibodi hospital medical records
排除标准
- •1.No available data in Ramathibodi hospital medical records
研究者
相似试验
招募中
不适用
ational urothelial carcinoma registry for recording and improving the quality of care across sectorsC67C65C66C68Malignant neoplasm of bladderMalignant neoplasm of renal pelvisMalignant neoplasm of ureterMalignant neoplasm of other and unspecified urinary organsDRKS00026204d-uo | Deutsche Uro-Onkologen e.V.6,150
已完成
不适用
Renal Mass RegistryRenal Cell CarcinomaNCT01887574Mayo Clinic141
尚未招募
不适用
Analysis of data of a clinical cancer registry for head and neck carcinomaC00-C14C32Malignant neoplasms of lip, oral cavity and pharynxMalignant neoplasm of larynxDRKS00023378Klinik für Hals-Nasen-Ohrenheilkunde, Kopf- und Halschirurgie, Universitätsklinikum Freiburg4,000
尚未招募
Unknown
A prospective database for neuroendocrine cancer (NET) patients recommended for peptide radionuclide receptor therapy (PRRT): The New Zealand PRRT Databaseeuroendocrine cancerPeptide radionuclide receptor therapy (PRRT)Neuroendocrine cancerCancer - Neuroendocrine tumour (NET)ACTRN12624000367549The University of Auckland40
进行中（未招募）
不适用
Carcinome rénal à cellules claires (CRCC) traité par molécules antiangiogéniques en situation adjuvante: valeur pronostique et thérapeutique des altérations du gène VHL et de l’expression plasmatique et intratumorale des molécules impliquées dans la voie VHL/HIF/VEGF. - S-TRACCarcinome rénal à cellules claires (CRCC) traité par molécules antiangiogéniques en situation adjuvanteMedDRA version: 9.1Level: LLTClassification code 10001326Term: Adrenal carcinomaMedDRA version: 9.1Level: LLTClassification code 10001327Term: Adrenal carcinoma NOSMedDRA version: 9.1Level: LLTClassification code 10038395Term: Renal carcinomaMedDRA version: 9.1Level: LLTClassification code 10038396Term: Renal carcinoma recurrentMedDRA version: 9.1Level: LLTClassification code 10038397Term: Renal carcinoma stage IMedDRA version: 9.1Level: LLTClassification code 10038398Term: Renal carcinoma stage IIMedDRA version: 9.1Level: LLTClassification code 10038399Term: Renal carcinoma stage IIIMedDRA version: 9.1Level: LLTClassification code 10038400Term: Renal carcinoma stage IVMedDRA version: 9.1Level: LLTClassification code 10050076Term: Metastatic renal carcinomaMedDRA version: 9.1Level: PTClassification code 10001326Term: Adrenal carcinomaEUCTR2007-005648-25-FRC.H.U. de RENNES